The 2014 meeting will again include representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry to discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers or genetic information.
NCDEU Registration & Housing Site: opens early January
New Investigator Awards: January 10, 2014
Posters: February 10, 2014
Abstract submission is open.